Yeoh Cn, Lee Cy
Department of Anesthesia and Intensive Care, Hospital Kuala Lumpur, Malaysia.
J Anaesthesiol Clin Pharmacol. 2012 Apr;28(2):205-9. doi: 10.4103/0970-9185.94869.
Venous cannulation is often a painful procedure for the patient. Eutectic mixture of local anesthetic (EMLA) is the commonest topical analgesic used but suffers from disadvantages such as slow onset and skin blanching, which may interfere with venous cannulation. Amethocaine is a newer topical analgesic which seems to be devoid of such problems.
This prospective randomized double-blind study compared the analgesic efficacy of EMLA with amethocaine during venous cannulation in adults. Eighty ASA I-II patients, aged 18-65 years, were recruited. The test drug was applied on the designated site of venous cannulation and covered with an occlusive dressing for at least 60 min prior to the procedure. Data collected included visual analogue score (VAS) during first attempt at venous cannulation, the ease and success rate at cannulation, and cutaneous changes at the application site.
Mean and median VAS for the EMLA group were 27.9 ± 9.8 and 30 mm, respectively; while for the Amethocaine group were 19.1 ± 14.1 and 20 mm, respectively. Differences in VAS did not reach statistical significance. No statistically significant differences were observed in the ease and success rate at cannulation. Cutaneous changes in the form of local induration and erythema (three patients in the Amethocaine group) and blanching (eight patients in the EMLA group) were mild, localized, and required no further treatment. No patient developed severe allergic reactions.
Topical EMLA and amethocaine were comparable in terms of analgesic efficacy and ease of venous cannulation in adult patients.
静脉置管对患者来说通常是一种痛苦的操作。局部麻醉剂的 eutectic 混合物(EMLA)是最常用的局部镇痛药,但存在起效缓慢和皮肤变白等缺点,这可能会干扰静脉置管。丁卡因是一种较新的局部镇痛药,似乎没有这些问题。
这项前瞻性随机双盲研究比较了 EMLA 和丁卡因在成人静脉置管过程中的镇痛效果。招募了 80 名年龄在 18 - 65 岁的美国麻醉医师协会(ASA)I - II 级患者。在操作前,将试验药物涂抹在静脉置管的指定部位,并用封闭敷料覆盖至少 60 分钟。收集的数据包括首次静脉置管时的视觉模拟评分(VAS)、置管的难易程度和成功率,以及应用部位的皮肤变化。
EMLA 组的平均 VAS 和中位数 VAS 分别为 27.9 ± 9.8 和 30 mm;而丁卡因组分别为 19.1 ± 14.1 和 20 mm。VAS 的差异未达到统计学显著性。在置管的难易程度和成功率方面未观察到统计学显著差异。以局部硬结和红斑形式出现的皮肤变化(丁卡因组 3 例患者)和皮肤变白(EMLA 组 8 例患者)较轻,局限于局部,无需进一步治疗。没有患者发生严重过敏反应。
在成人患者中,局部应用 EMLA 和丁卡因在镇痛效果和静脉置管的难易程度方面具有可比性。